Teva Pharmaceutical Industries TEVA
NYSE TEVA
$39.53 +0.20 (+0.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Teva Pharmaceutical Industries (TEVA) Asset Writedowns and Impairment (2009 - 2026)

Updated

Teva Pharmaceutical Industries' Asset Writedowns and Impairment was $113 million in Q2 2026, up 14.1% from $99 million a year earlier.

Analysis

Teva Pharmaceutical Industries (TEVA) Asset Writedowns and Impairment (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Teva Pharmaceutical Industries' Asset Writedowns and Impairment was $975 million through Jun 30, 2026, down 7.7% year-over-year; for FY2025, it was $1.03 billion, down 19.7% from FY2024.

  • Asset Writedowns and Impairment shows a five-year compound annual growth rate of -30.9% (FY2020 to FY2025).
  • In earlier years, Asset Writedowns and Impairment was $1.28 billion in FY2024 (+82.9%), $700 million in FY2023 (-65.8%), $2.05 billion in FY2022 (+250.2%) and $584 million in FY2021 (-91.1%).
  • Quarterly Asset Writedowns and Impairment has moved between $10 million (Q1 2026) and $1.04 billion (Q4 2022) over five years.
  • Compared with a year earlier, Asset Writedowns and Impairment was higher in two of the last six quarters, with an average decline of 24.6%.
  • The best year-over-year quarter for Asset Writedowns and Impairment over five years was Q4 2022 (growth of 469.9%); the worst was Q3 2021 (a decline of 99.1%).
  • Per Business Quant data, TEVA's Asset Writedowns and Impairment in the three quarters before Q2 2026 was $10 million (Q1 2026), $773 million (Q4 2025) and $79 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Teva Pharmaceutical Industries 46.06 Bn 32.91 Bn 2.15 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 113.00 Mn
Mar 31, 2026 10.00 Mn
Dec 31, 2025 773.00 Mn
Sep 30, 2025 79.00 Mn
Jun 30, 2025 99.00 Mn
Mar 31, 2025 77.00 Mn
Dec 31, 2024 280.00 Mn
Sep 30, 2024 600.00 Mn
Jun 30, 2024 400.00 Mn
Mar 31, 2024 679.00 Mn
Sep 30, 2023 48.00 Mn
Jun 30, 2023 511.00 Mn
Mar 31, 2023 189.00 Mn
Dec 31, 2022 1.04 Bn
Sep 30, 2022 28.00 Mn
Jun 30, 2022 810.00 Mn
Mar 31, 2022 165.00 Mn
Dec 31, 2021 183.00 Mn
Sep 30, 2021 47.00 Mn
Jun 30, 2021 227.00 Mn
API Access

Teva Pharmaceutical Industries Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=TEVA&period=max&api_key=YOUR_API_KEY